Skip to main content
. 2021 Jul 28;8(4):589–601. doi: 10.1007/s40801-021-00262-7

Table 1.

Characteristics of adverse drug reactions (ADRs)

Characteristic ADRs ADRs/MDADsa
N %
Seriousness
Non-serious ADRs 5331 96.8 1.45
Serious ADRs 104 1.9 0.03
Not applicableb 71 1.3 0.02
Total 5506 100.0 1.50
Causality
Certain 615 11.2 0.17
Probable/likely 393 7.1 0.11
Possible 3711 67.4 1.01
Not assessable 679 12.3 0.18
Not applicableb 108 2.0 0.03
Total 5506 100.0 1.50
Outcome
Recovered/resolved 3732 67.8 1.02
Recovering/resolving 318 5.8 0.09
Recovered/resolved with sequelae 13 0.2 0.00
Sequelae 1 0.0 0.00
Not recovered/not resolved 266 4.8 0.07
Fatal 0 0.0 0.00
Unknown 1097 19.9 0.30
Not assessable 2 0.0 0.00
Not applicableb 77 1.4 0.02
Total 5506 100.0 1.50
Labellingc
Yes 3342 60.7 0.91
No 1854 33.7 0.50
Equivalentd 127 2.3 0.03
Not applicableb 110 2.0 0.03
Unknown 52 0.9 0.01
Not assessed 20 0.4 0.01
No approval in 1 0.0 0.00
Total 5506 100.0 1.50

MDADs maximum daily administration doses sold, AMP anthroposophic medicinal product

a× 1 million

bNot applicable: incorrect use of the AMP, the ADR was reported in terms of lack of effect or similar, or the ADR was evaluated to be causally linked to another AMP that was concomitantly administered in that patient

cLabelling information on the ADR in the patient information leaflet

dEquivalent (similar) to the labelling of the ADR in the patient information leaflet